Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1550, 2006-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Second generation pneumococcal vaccines: which is best in Norway?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640, 2011-01 ,pp. :
Access to resources
Recommend
Pneumococcal conjugate vaccine potentially cost saving in the US
Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. :
Influenza vaccine cost saving in healthy, working-age adults?
Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. :
Influenza vaccine cost saving in healthy, working-age adults?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. :
Is the evidence recommending pneumococcal vaccine valid?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :